From: MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications
Method | Execution time | Sample input | Cost | Advantages | Disadvantages |
---|---|---|---|---|---|
qPCR | <6 hours | 10-500Â ng | <$300 | High sensitivity, large dynamic range (~6 orders of magnitude), reproducibility, accessibility, compatible with several sources of biological material | Low throughput, unable to detect novel or modified miRNAs, variability across platforms |
Microfluidic qPCR platforms | <6 hours | 10-500Â ng | <$300 | High throughput, high sensitivity, large dynamic range (~6 orders of magnitude), reproducibility, compatible with several sources of biological material | Unable to detect novel or modified miRNAs, variability across platforms |
Microarray | 48 hours | 100 ng-1 μg | ~$300 | High throughput, well optimized, well established analysis methods | Generally cannot distinguish mature from pre-miRNAs, might require a non-specific amplification step |
Next generation sequencing | 2 weeks | 500 ng-5 μg | >$1000 | High throughput, useful for miRNA discovery and modified miRNA detection, high sensitivity, large dynamic range (~5 orders of magnitude) | Large investment and bioinformatics expertise required, slow turnover, may suffer from non-linearity in the amplification step |